•
Dec 31, 2023

NeueHealth Q4 2023 Earnings Report

Reported strong full year results in Continuing Business and focused on serving all populations through differentiated, value-driven care model.

Key Takeaways

NeueHealth reported Q4 and full year 2023 results, highlighting a focus on care delivery and provider enablement after the sale of the California Medicare Advantage business. The NeueHealth business drove strong results in 2023, delivering $1.2 billion in revenue, up 55% year over year, and serving 461,000 consumers across the country.

Delivered strong full year 2023 results in Continuing Business

Focused on serving all populations through differentiated, value-driven care model

Served 461,000 consumers, an increase of 294% from prior year on a comparable basis

NeueCare and NeueSolutions segments well-positioned to drive strong performance in 2024

Total Revenue
$293M
Previous year: $551M
-46.9%
EPS
$19.5
Previous year: -$27.2
-171.8%
Gross Profit
$293M
Previous year: -$2.63B
-111.1%
Cash and Equivalents
$87.3M
Previous year: $217M
-59.8%
Free Cash Flow
-$331M
Previous year: $117M
-383.8%
Total Assets
$1.23B
Previous year: $4.67B
-73.7%

NeueHealth

NeueHealth

NeueHealth Revenue by Segment

Forward Guidance

For full year 2024, NeueHealth is providing the following guidance and commentary:

Positive Outlook

  • NeueHealth’s Enterprise Revenue is expected to be approximately $1 billion
  • NeueCare Revenue is expected to be between $310 million and $320 million
  • NeueSolutions Revenue is expected to be between $690 million and $700 million
  • Enterprise Adjusted Operating Cost Ratio is expected to be between 15% and 16%
  • Enterprise Adjusted EBITDA is expected to be between $15 million and $25 million in 2024

Revenue & Expenses

Visualization of income flow from segment revenue to net income